219.78MMarket Cap-1862P/E (TTM)
1.580High1.450Low242.91KVolume1.470Open1.470Pre Close365.67KTurnover0.23%Turnover RatioLossP/E (Static)147.50MShares5.25052wk High1.30P/B157.81MFloat Cap0.39352wk Low--Dividend TTM105.91MShs Float13.780Historical High--Div YieldTTM8.84%Amplitude0.393Historical Low1.505Avg Price1Lot Size
Renovaro Stock Forum
NEWS
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
RenovaroCube acquires 100% ownership of Cyclomics, solidifying their collaboration in cancer diagnostics.
The partnership with Oxford Nanopore and Nvidia enhances RenovaroCube's capabilities in early cancer detection and treatment monitoring.
RenovaroCube's open architecture AI platform combined with Cyclomics' 4th generation molecular technology enables accurate ...
The two companies have agreed to merge, with artificial intelligence medical technology firm GEDi becoming a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
No comment yet